Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

There are multiple treatment options for an overactive bladder.

The 'polar vortex' that gripped much of the country this week has not stopped pharmacists from helping patients.

Andrea Cusack, RPh, has made national headlines braving treacherous conditions delivering prescriptions in a very creative way.

With new products coming to the pharmacy market, such as smart devices and digital medicines, the profession will need to develop quickly to keep up pace.

The 2 companies are joining the women’s heart health initiative to promote awareness for cardiovascular disease prevention.

Mylan's drug is approved for 100 mcg/50 mcg, 250 mcg/50 mcg, and 500 mcg/50 mcg doses.

As pharmacists, we manage and supervise people on a daily basis. It is important to distinguish what type of leader you are and which styles are more effective when dealing with different people in the pharmacy.

Screening for and treatment of gonorrhea in pregnant women are also important strategies for preventing gonococcal ophthalmia neonatorum in babies, according to the Task Force.

The affected lots have been found to contain levels of ibuprofen concentration that are higher than the specified limit.

The FDA has approved sumatriptan nasal spray (Tosymra, Promius Pharma) for the acute treatment of migraine with or without aura in adults.

Recognizing the ongoing opioid crisis and the need to deter theft of drugs, at least 2 medical technology companies—BD and Invistics—have come up with promising digital solutions that track how medications are being dispensed.

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

Rite Aid pharmacies are providing measles-mumps-rubella (MMR) vaccinations in 2 states that are seeing an increase in reported measles cases.

The Howard University College of Pharmacy was recently awarded an $85,899 grant to educate the region’s pharmacists and pharmacy technicians on the dangers of opioid addiction and abuse.

A prescription drug ad broadcast during the musical on television has set the stage for a larger conversation about patient access to preexposure prophylaxis medication.

Syphilis is a sexually transmitted infection that has increased significantly among pregnant women and newborns.

The FDA has approved the use of ibrutinib (Imbruvica®, AbbVie) in combination with obinutuzumab (Gazyva®) for adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Can you solve the pharmaceutical mystery?

Health Mart has named Nimesh Jhaveri, MBA, RPh, its new president.

Conducted by the FDA, an analysis follows a series of recalls for some generic versions of the angiotensin II receptor blocker (ARB) medicines containing nitrosamine impurities that do not meet the agency’s safety standards.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

I firmly believe that overall pharmacy knowledge should increase over time.

Because high triglycerides have been associated with an increased risk for CVD, lowering this lab value should also reduce circulatory system risks.

A novel inhaled product was approved in late 2018 for Parkinson Disease.

A public awareness campaign aimed at highlighting the value of the pharmacist has entered its second phase following a successful first phase.

Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP.

Two lawsuits filed against Walgreens have been settled with the national drug store chain agreeing to pay a total of more than $260 million.

The report authors noted that people with type 1 diabetes spent $5,705 on insulin in 2016, up from $2,864 in 2012.

Teva has just unveiled the world's first integrated smart inhaler to the market.